Cargando…

Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer

BACKGROUND: The effectiveness of immune checkpoint inhibitors in treating gallbladder cancer (GBC) remains unsatisfactory. Recently, several new immune checkpoints have been identified. However, investigations exploring these immune checkpoints in GBC are limited. In this study, we aim to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xing, Peng, Yaorong, He, Gui, Ye, Huilin, Liu, Liqiang, Zhou, Qixian, Shi, Juanyi, Fu, Sha, Wang, Jie, Zhou, Zhenyu, Li, Wenbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571407/ https://www.ncbi.nlm.nih.gov/pubmed/37828574 http://dx.doi.org/10.1186/s12967-023-04589-3

Ejemplares similares

Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
por: Wu, Zhengwei, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Based Systemic Therapy Shows Remarkable Curative Effect in a Hepatocellular Carcinoma Patient With Intractable Postoperative Recurrence and Metastases: A Case Report and Literature Review
por: He, Xing, et al.
Publicado: (2022)

Overexpression of Thy1 and ITGA6 is associated with invasion, metastasis and poor prognosis in human gallbladder carcinoma
por: Zhang, Dan-Hua, et al.
Publicado: (2016)

Single-cell RNA-seq reveals transcriptional landscape and intratumor heterogenicity in gallbladder cancer liver metastasis microenvironment
por: Zhang, Yigang, et al.
Publicado: (2021)

PD‐1+ TIM‐3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer
por: Nakano, Michitaka, et al.
Publicado: (2018)

Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma
por: Wang, Peipei, et al.
Publicado: (2021)

Differential expression of PD-1 and Tim-3 marks activation versus exhaustion status of T cells in the tumor microenvironment
por: Li, Jing, et al.
Publicado: (2014)

Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
por: Jiang, Jing, et al.
Publicado: (2013)

Elevated Platelet Distribution Width Predicts Poor Prognosis in Gallbladder Carcinoma
por: Liu, Fei, et al.
Publicado: (2021)

Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Cancer
por: Lu, Wei, et al.
Publicado: (2015)

TIM-3(+) T cells are not exhausted but activated cells in the tumor microenvironment
por: Jie, Hyun-Bae, et al.
Publicado: (2013)

Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
por: Tian, Tian, et al.
Publicado: (2021)

Search for the Doubly Charmed Baryon Ξ+cc in Ξ+cc → pD+K−
por: Yang, Juanyi
Publicado: (2021)

The structure of Tim50(164–361) suggests the mechanism by which Tim50 receives mitochondrial presequences
por: Li, Jingzhi, et al.
Publicado: (2015)

PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load
por: Zhou, Yajuan, et al.
Publicado: (2017)

The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer
por: Kozłowski, Mateusz, et al.
Publicado: (2022)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

PD-L2 based immune signature confers poor prognosis in HNSCC
por: Qiao, Yu, et al.
Publicado: (2021)

Research progress on the immune microenvironment of the gallbladder in patients with cholesterol gallstones
por: Jiao, Jing-Yi, et al.
Publicado: (2022)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis for Gallbladder Carcinoma
por: Zhai, Guojun, et al.
Publicado: (2012)

CREM Is Correlated With Immune-Suppressive Microenvironment and Predicts Poor Prognosis in Gastric Adenocarcinoma
por: Yu, Kuai, et al.
Publicado: (2021)

Tumor microenvironment heterogeneity in bladder cancer identifies biologically distinct subtypes predicting prognosis and anti-PD-L1 responses
por: Li, YaFei, et al.
Publicado: (2023)

TIM-3, a promising target for cancer immunotherapy
por: He, Yayi, et al.
Publicado: (2018)

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
por: Wu, Junlong, et al.
Publicado: (2017)

Agrin expression is correlated with tumor development and poor prognosis in cholangiocarcinoma
por: He, Meimei, et al.
Publicado: (2021)

Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis
por: Suguro, Miyuki, et al.
Publicado: (2014)

VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma
por: He, Hai-Xia, et al.
Publicado: (2021)

Elevation of Tim-3 and PD-1 Expression on T Cells Appears Early in HIV Infection, and Differential Tim-3 and PD-1 Expression Patterns Can Be Induced by Common γ-Chain Cytokines
por: Zhang, Zi-Ning, et al.
Publicado: (2015)

Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
por: Bruss, Christina, et al.
Publicado: (2023)

Gallbladder microbiota composition is associated with pancreaticobiliary and gallbladder cancer prognosis
por: Kirishima, Mari, et al.
Publicado: (2022)

Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer
por: Cao, Yang, et al.
Publicado: (2016)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma
por: Zhang, Dawei, et al.
Publicado: (2023)

sTim-3 alleviates liver injury via regulation of the immunity microenvironment and autophagy
por: Yang, Ying, et al.
Publicado: (2020)

Neuroendocrine neoplasm of the gallbladder: Clinical features, surgical efficacy, and prognosis
por: Wu, Xin, et al.
Publicado: (2023)

PD-1 and Tim-3 Pathways Regulate CD8(+) T Cells Function in Atherosclerosis
por: Qiu, Ming-Ke, et al.
Publicado: (2015)

Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the gallbladder
por: Wang, Shijie, et al.
Publicado: (2021)

Tim Burton /
por: Marcos Arza, Marcos
Publicado: (2007)

Tim Lou
por: Lou, Hou Keong
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_fnv5i4mua5f8v2miblck2tdh68